New federal rule requires drug middlemen to disclose how they’re paid

The Trump administration released a final rule Thursday requiring pharmacy benefit managers (PBMs) to disclose all payment methods to clients. The Department of Labor rule covers companies managing billions in prescription drug spending for employers and workers, aiming to increase transparency in how PBMs are compensated and reduce hidden fees in the drug supply chain.